New Zealand (NZX) Biotech Industry Analysis
UpdatedJan 28, 2023
DataAggregated Company Financials
Companies1
- 7D-3.1%
- 3M10.5%
- 1Y-58.0%
- YTD-4.0%
Over the last 7 days, the Biotech industry has dropped 2.0%, driven by declines from every company within the industry. However, the industry is down 58% over the past year. Earnings are forecast to grow by 13% annually.
Industry Valuation and Performance
Has the New Zealand Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 28 Jan 2023 | NZ$397.1m | NZ$16.5m | -NZ$21,374,000.00 | n/a | -18.6x | 24.1x |
| Mon, 26 Dec 2022 | NZ$405.2m | NZ$16.5m | -NZ$21,374,000.00 | n/a | -19x | 24.6x |
| Wed, 23 Nov 2022 | NZ$392.9m | NZ$13.1m | -NZ$19,788,000.00 | n/a | -19.9x | 29.9x |
| Fri, 21 Oct 2022 | NZ$360.5m | NZ$13.1m | -NZ$19,788,000.00 | n/a | -18.2x | 27.4x |
| Sun, 18 Sep 2022 | NZ$413.2m | NZ$13.1m | -NZ$19,788,000.00 | n/a | -20.9x | 31.5x |
| Tue, 16 Aug 2022 | NZ$413.2m | NZ$13.1m | -NZ$19,788,000.00 | n/a | -20.9x | 31.5x |
| Thu, 14 Jul 2022 | NZ$575.2m | NZ$13.1m | -NZ$19,788,000.00 | n/a | -29.1x | 43.8x |
| Sat, 11 Jun 2022 | NZ$583.3m | NZ$13.1m | -NZ$19,788,000.00 | n/a | -29.5x | 44.4x |
| Mon, 09 May 2022 | NZ$713.0m | NZ$11.5m | -NZ$16,115,000.00 | n/a | -44.2x | 61.9x |
| Wed, 06 Apr 2022 | NZ$802.0m | NZ$11.5m | -NZ$16,115,000.00 | n/a | -49.8x | 69.6x |
| Fri, 04 Mar 2022 | NZ$769.5m | NZ$11.5m | -NZ$16,115,000.00 | n/a | -47.8x | 66.8x |
| Sun, 30 Jan 2022 | NZ$947.7m | NZ$11.5m | -NZ$16,115,000.00 | n/a | -58.8x | 82.3x |
| Tue, 28 Dec 2021 | NZ$1.1b | NZ$11.5m | -NZ$16,115,000.00 | n/a | -65.8x | 92.1x |
| Thu, 25 Nov 2021 | NZ$1.1b | NZ$9.0m | -NZ$14,223,000.00 | n/a | -79.7x | 126.3x |
| Sat, 23 Oct 2021 | NZ$1.2b | NZ$9.0m | -NZ$14,223,000.00 | n/a | -83.6x | 132.5x |
| Mon, 20 Sep 2021 | NZ$1.1b | NZ$9.0m | -NZ$14,223,000.00 | n/a | -76.4x | 121.1x |
| Wed, 18 Aug 2021 | NZ$903.9m | NZ$9.0m | -NZ$14,223,000.00 | n/a | -63.6x | 100.7x |
| Wed, 02 Jun 2021 | NZ$866.1m | NZ$9.0m | -NZ$14,223,000.00 | n/a | -60.9x | 96.5x |
| Sat, 06 Mar 2021 | NZ$756.6m | NZ$7.6m | -NZ$15,406,500.00 | n/a | -49.1x | 99.3x |
| Tue, 08 Dec 2020 | NZ$515.0m | NZ$6.3m | -NZ$16,590,000.00 | n/a | -31x | 82.1x |
| Mon, 31 Aug 2020 | NZ$470.7m | NZ$5.6m | -NZ$17,738,000.00 | n/a | -26.5x | 83.9x |
| Thu, 04 Jun 2020 | NZ$82.8m | NZ$4.9m | -NZ$18,886,000.00 | n/a | -4.4x | 16.8x |
| Sun, 08 Mar 2020 | NZ$85.5m | NZ$4.9m | -NZ$18,737,000.00 | n/a | -4.6x | 17.4x |
Price to Earnings Ratio
-4.3x
Current Industry PE
- There is only one company in the New Zealander Biotechnology industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 50% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Comparison
How does New Zealand Biotech compare with similar industries?
| NZ Market | 0.45% | |
| Healthcare | 0.31% | |
| Biotech | -3.06% | |
| Biotech | -3.06% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| No data available | |||||